NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment (NCT06087744)
Effects of a Parent-preterm Proximity and Calm Intervention (NeuroN-QI) on the Neurodevelopment of Preterm Infants: A Randomized Pragmatic Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without manipulation with olfactory stimulation with breast milk in the incubator/bed both combined with appropriate light and noise levels to promote neurodevelopment preterm infants.
Who can join: Review the eligibility criteria below.
Location: CHU Sainte-Justine — Montreal, Quebec
Age range: 24 Weeks to 34 Weeks
🧪 Interventions in This Study
- NeuroN-QI (BEHAVIORAL)
- SSC alone (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- CHU Sainte-Justine — Montreal, Quebec
- CUSM — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (514) 343-6111
Email: marilyn.aita@umontreal.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Neurodevelopmental Disorders
- Evaluation of the Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach) — Edmonton, Alberta
- Reducing Missed Appointments — Baltimore, Maryland
- Patterns of Neurodevelopmental Disorders — Phoenix, Arizona
- Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders — The Woodlands, Texas
- Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders — Calgary, Alberta
Explore by condition: All Neurodevelopmental Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.